Overexpression of Calreticulin Contributes to the Development and Progression of Pancreatic Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Calreticulin Contributes to the Development and Progression of Pancreatic Cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 229, Issue 7, Pages 887-897
Publisher
Wiley
Online
2013-11-23
DOI
10.1002/jcp.24519
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer
- (2013) Weiwei Sheng et al. CELL AND TISSUE RESEARCH
- Current concepts and novel targets in advanced pancreatic cancer
- (2012) Patrick Michl et al. GUT
- Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer
- (2012) Weiwei Sheng et al. JOURNAL OF SURGICAL ONCOLOGY
- Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-Regulation of Calreticulin Expression
- (2011) Yi-Chien Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- Calreticulin as a potential diagnostic biomarker for lung cancer
- (2011) Rongrong Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Calreticulin is crucial for calcium homeostasis mediated adaptation and survival of thick ascending limb of Henle's loop cells under osmotic stress
- (2011) Asima Bibi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Calreticulin Mediates Nerve Growth Factor-Induced Neuronal Differentiation
- (2011) Yu-Yin Shih et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Low Expression of Claudin-4 is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2010) Chang Ohk Sung et al. ANNALS OF SURGICAL ONCOLOGY
- Clinicopathological significance of calreticulin in breast invasive ductal carcinoma
- (2010) Zin-Mar Lwin et al. MODERN PATHOLOGY
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
- (2010) E Bobrovnikova-Marjon et al. ONCOGENE
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
- (2010) M Wemeau et al. Cell Death & Disease
- Suppressive Roles of Calreticulin in Prostate Cancer Growth and Metastasis
- (2009) Mahesh Alur et al. AMERICAN JOURNAL OF PATHOLOGY
- Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum
- (2009) Marek Michalak et al. BIOCHEMICAL JOURNAL
- Urinary calreticulin in the diagnosis of bladder urothelial carcinoma
- (2009) Susumu Kageyama et al. INTERNATIONAL JOURNAL OF UROLOGY
- Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3–CTTN–Akt pathway in esophageal squamous cell carcinoma
- (2009) X-L Du et al. ONCOGENE
- Effects of Humoral Immunity and Calreticulin Overexpression on Postoperative Course in Breast Cancer
- (2009) Aleksandra Erić et al. PATHOLOGY & ONCOLOGY RESEARCH
- Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer
- (2008) Chiung-Nien Chen et al. ANNALS OF SURGICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now